Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DIH Holding US's share price for the quarter that ended in Mar. 2025 was $5.7825. DIH Holding US's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 1.69 Mil. Therefore, DIH Holding US's market cap for the quarter that ended in Mar. 2025 was $9.77 Mil.
DIH Holding US's quarterly market cap
declined
from Sep. 2024 ($2.63 Mil) to Dec. 2024 ($1.92 Mil) but then
increased
from Dec. 2024 ($1.92 Mil) to Mar. 2025 ($9.77 Mil).
DIH Holding US's annual market cap
increased
from Mar. 2023 ($0.00 Mil) to Mar. 2024 ($1.52 Mil) and
increased
from Mar. 2024 ($1.52 Mil) to Mar. 2025 ($9.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DIH Holding US's Enterprise Value for Today is $12.95 Mil.
DIH Holding US (OTCPK:DHAI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DIH Holding US Market Cap Related Terms
DIH Holding US Market Cap Historical Data
* Premium members only.
The historical data trend for DIH Holding US's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DIH Holding US's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DIH Holding US Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DIH Holding US's Market Cap distribution charts can be found below:
* The bar in red indicates where DIH Holding US's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DIH Holding US's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DIH Holding US (DHAI) has a Market Cap of $0.00 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DIH Holding US and its competitors.
Is DIH Holding US's Market Cap too high?
DIH Holding US's current Market Cap is $0.00 Mil.
How does DIH Holding US's Market Cap compare to ABT and SYK?
DIH Holding US's Market Cap of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. The industry median Market Cap is 118.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DIH Holding US and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DIH Holding US's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Market Cap is $0.00 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHAI has been successfully added to your 